Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,575 | -21,104 | -94,465 | -72,796 | -50,067 |
| Depreciation Amortization | 3,145 | 1,582 | 6,649 | 5,041 | 3,353 |
| Accounts receivable | -1,282 | 813 | 1,735 | 4,025 | 1,186 |
| Accounts payable and accrued liabilities | -384 | 22 | -1,754 | -1,845 | -681 |
| Other Working Capital | -669 | -831 | -6 | 1,728 | 941 |
| Other Operating Activity | 6,783 | 1,943 | 11,019 | 5,248 | 4,318 |
| Operating Cash Flow | $-33,982 | $-17,575 | $-76,822 | $-58,599 | $-40,950 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,151 | -5,286 | 63,495 | 30,852 | 14,469 |
| PPE Investments | -577 | -297 | -1,703 | -1,263 | -781 |
| Investing Cash Flow | $-12,728 | $-5,583 | $61,792 | $29,589 | $13,688 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,766 | 19,766 | N/A | N/A | 0 |
| Common Stock Issued | 21,237 | 9,890 | 2,705 | 2,703 | 2,020 |
| Financing Cash Flow | $41,003 | $29,656 | $2,705 | $2,703 | $2,020 |
| Beginning Cash Position | 46,540 | 46,540 | 58,865 | 58,865 | 58,865 |
| End Cash Position | 40,833 | 53,038 | 46,540 | 32,558 | 33,623 |
| Net Cash Flow | $-5,707 | $6,498 | $-12,325 | $-26,307 | $-25,242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,982 | -17,575 | -76,822 | -58,599 | -40,950 |
| Capital Expenditure | -577 | -297 | -1,703 | -1,263 | -781 |
| Free Cash Flow | -34,559 | -17,872 | -78,525 | -59,862 | -41,731 |